Global Digital Therapeutics for CNS Disorders Market - Strategic Insights and Forecasts (2026-2035)

The Global Digital Therapeutics for CNS Disorders Market is projected to grow at a CAGR of 22.1% during the forecast period, increasing from USD 4.24 billion in 2026 to USD 25.61 billion by 2035 due to rising CNS disorder prevalence and adoption of software-based therapies.

The Global Digital Therapeutics for CNS Disorders Market is driven by increasing prevalence of depression, anxiety, ADHD, and cognitive disorders, along with growing adoption of remote care models and rising demand for scalable behavioral and cognitive interventions.

The Global Digital Therapeutics for CNS Disorders Market is important because it provides continuous behavioral support, cognitive training, and symptom monitoring beyond traditional clinical visits, improving treatment adherence and long-term disease management.

The Global Digital Therapeutics for CNS Disorders Market offers opportunities in prescription digital therapeutics, neurorehabilitation digitization, and AI-enabled personalized treatment platforms that improve engagement and clinical outcomes.

The Global Digital Therapeutics for CNS Disorders Market faces restraints such as limited reimbursement frameworks, declining patient engagement over time, and strict regulatory and data privacy requirements.